Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others. Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.
Signs non-binding term sheet granting global rights to develop and commercialize oral MAT2203 for invasive aspergillosis and potentially other invasive fungal infections 31 patients have enrolled...
BEDMINSTER, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...
BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...
BEDMINSTER, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...
BEDMINSTER, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.18 | 6 | 3 | 3.3493 | 2.96 | 32930 | 3.1818229 | CS |
4 | -0.49 | -13.3514986376 | 3.67 | 4.1599 | 2.95 | 37963 | 3.36819645 | CS |
12 | -6.17 | -65.9893048128 | 9.35 | 9.35 | 2.95 | 765334 | 6.38933469 | CS |
26 | -7.11 | -69.0962099125 | 10.29 | 10.745 | 2.95 | 844325 | 7.66275889 | CS |
52 | -10.325 | -76.4531654943 | 13.505 | 44.5 | 2.95 | 3065619 | 21.23387344 | CS |
156 | -49.82 | -94 | 53 | 63 | 2.95 | 1448297 | 24.63297369 | CS |
260 | -31.32 | -90.7826086957 | 34.5 | 124.5 | 2.95 | 1908334 | 42.48045436 | CS |
Symbole | Prix | Vol. |
---|---|---|
YANGDirexion Daily FTSE China Bear 3X Shares New | US$ 3,187 (-1,64%) | 93,9M |
FXIiShares China Large Cap | US$ 33,45 (0,69%) | 69,11M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 38,67 (2,22%) | 58,43M |
XLFFinancial Select Sector | US$ 46,51 (1,93%) | 51,9M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 18,96 (-2,27%) | 47,86M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales